文献速递乳腺技术与安全PETCT

18F-16α-17β-氟雌二醇在雌激素受体阳性乳腺癌中的结合特异性

18F-16α-17β-Fluoroestradiol Binding Specificity in Estrogen Receptor-Positive Breast Cancer.
PubMed 文献 · Radiology · 2017-09-25

研究通过构建表达野生型或G521R突变型ERα的MDA-MB-231乳腺癌细胞及移植瘤模型,用体外摄取实验和小动物PET/CT评估FES结合特异性。结果显示G521R突变使ERα转录功能丧失,体外FES结合降至亲本细胞水平,体内突变型移植瘤FES摄取(%ID/g 0.49±0.042)与阴性对照(0.42±0.051,P=0.20)及肌肉非特异性摄取(0.41±0.0095,P=0.06)无显著差异。结论表明FES与ERα结合具有高特异性,依赖完整的受体配体结合口袋。

要点

  • FES摄取依赖ERα配体结合口袋完整,G521R突变型移植瘤摄取与阴性对照无显著差异(P=0.20)。
  • FES成像可能有助于定位免疫组化ER阳性但缺乏受体结合功能的转移灶,评估肿瘤异质性。

核心结论

  • FES在ER阳性乳腺癌中的滞留严格依赖完整的受体配体结合口袋,FES以高特异性与ERα结合;结果支持FES成像用于评估肿瘤异质性,定位免疫组化ER阳性但缺乏受体结合功能的转移灶。

研究设计与样本

  • 研究经生物安全办公室和机构动物护理与使用委员会批准,用ER阴性MDA-MB-231乳腺癌细胞创建表达野生型(231 WT ER)或G521R突变型ERα(231 G521R ER)的克隆细胞系,并确认ERα蛋白水平、亚细胞定位和转录功能;体外用细胞摄取实验测FES结合,体内用小动物PET/CT对24只小鼠的移植瘤测FES摄取(17个WT ER瘤、9个突变G521R ER瘤、8个MDA-MB-231瘤、4个MCF-7 ER阳性瘤),统计用Mann-Whitney(Wilcoxon秩和)检验。

诊断标准与关键数值

  • 231 G521R ER突变细胞中ERα转录功能丧失,尽管受体蛋白表达和核定位正常。
  • 231 G521R ER细胞体外FES结合降至亲本细胞水平。
  • 231 G521R ER移植瘤FES摄取为%ID/g 0.49±0.042,与阴性对照MDA-MB-231移植瘤(%ID/g 0.42±0.051;P=0.20)及肌肉非特异性摄取(%ID/g 0.41±0.0095;P=0.06)无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To determine the binding specificity of 18F-16α-17β-fluoroestradiol (FES) in estrogen receptor (ER) α-positive breast cancer cells and tumor xenografts. Materials and Methods Protocols were approved by the office of biologic safety and institutional animal care and use committee. By using ER-negative MDA-MB-231 breast cancer cells, clonal lines were created that expressed either wild-type (WT; 231 WT ER) or G521R mutant ERα (231 G521R ER), which is defective in estradiol binding. ERα protein levels, subcellular localization, and transcriptional function were confirmed. FES binding was measured by using an in vitro cell uptake assay. In vivo FES uptake was measured in tumor xenografts by using small-animal positron emission tomographic/computed tomographic imaging of 24 mice (17 WT ER tumors, nine mutant G521R ER tumors, eight MDA-MB-231 tumors, and four MCF-7 ER-positive tumors). Statistical significance was determined by using Mann-Whitney (Wilcoxon rank sum) test. Results ERα transcriptional function was abolished in the mutated 231 G521R ER cells despite appropriate receptor protein expression and nuclear localization. In vitro FES binding in the 231 G521R ER cells was reduced to that observed in the parental cells. Similarly, there was no significant FES uptake in the 231 G521R ER xenografts (percent injected dose [ID] per gram, 0.49 ± 0.042), which was similar to the negative control MDA-MB-231 xenografts (percent ID per gram, 0.42 ± 0.051; P = .20) and nonspecific muscle uptake (percent ID per gram, 0.41 ± 0.0095; P = .06). Conclusion This study showed that FES retention in ER-positive breast cancer is strictly dependent on an intact receptor ligand-binding pocket and that FES binds to ERα with high specificity. These results support the utility of FES imaging for assessing tumor heterogeneity by localizing immunohistochemically ER-positive metastases that lack receptor-binding functionality. © RSNA, 2017 Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Salem K, Kumar M, Powers GL, et al. 18F-16α-17β-Fluoroestradiol Binding Specificity in Estrogen Receptor-Positive Breast Cancer. Radiology. 2017. PMID: 28956736. doi:10.1148/radiol.2017162956

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。